Incidence of Macular Edema in a Uveitis Population

Active, not recruitingOBSERVATIONAL
Enrollment

1,550

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

February 1, 2025

Conditions
Macular EdemaNon-infectious Uveitis
Interventions
DRUG

Local and systemical treatment

Evaluating the management of the edema including topical/local treatment (dexamethasone and NSAID, periocular injections, and dexamethasone intravitreal implant) and systemic treatment (prednisolone, DMARD, and biological agents, for example TNF-alpha inhibitors and interleukin-6 inhibitors). Moreover, the duration of any treatment as well as numbers of injections or implants.

Trial Locations (1)

9000

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Aalborg University Hospital

OTHER

NCT06686641 - Incidence of Macular Edema in a Uveitis Population | Biotech Hunter | Biotech Hunter